• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Psychiatry

Alcohol use declines but remains above pre-pandemic levels

byAdrian WongandMichaela Dowling
September 22, 2026
in Psychiatry, Public Health
Reading Time: 3 mins read
Share on FacebookShare on Twitter

1. In this cross-sectional study, both any and heavy alcohol use among US adults decreased from 2022 to 2024 but remained at or above prepandemic levels.

2. Absolute reductions in use of any alcohol were most prominent among males, Generation Z, and White participants.

Evidence Rating Level: 3 (Average)

Study Rundown: Alcohol-related mortality accelerated during the COVID-19 pandemic and continued to rise immediately afterward. Although a 2025 survey reported the first decline in alcohol consumption since the pandemic, these findings required validation. This study aimed to assess trends in alcohol use since 2022 and differences across demographic subgroups. Among more than 110,000 adults, the prevalence of both any and heavy alcohol use declined between 2022 and 2024. Reductions in any alcohol use were observed across most subgroups and were particularly pronounced among males, Generation Z, and White participants. Heavy alcohol use also declined, with notable reductions among adults aged 30 to 49 years, Millennials, White and non-Hispanic participants, and urban residents. Despite these declines, alcohol use in 2024 remained at or above 2018 prepandemic levels. From 2018 to 2024, any alcohol use increased among adults aged 50 to 64 years and participants living in the western United States, while heavy alcohol use increased among adults aged 50 to 64 years and Hispanic participants. Generalizability may be limited by self-reported outcomes and underrepresentation of military personnel and institutionalized adults. Overall, these findings suggest that although alcohol consumption has declined since its pandemic-era increase, alcohol use among U.S. adults remains elevated compared with prepandemic levels.

Click to read this study in AIM

Relevant Reading: Trends in Alcohol Use After the COVID-19 Pandemic: A National Cross-Sectional Study

RELATED REPORTS

Deficits in executive function are not universal among patients with alcohol use disorder

Few interventions improve posthospitalization follow-up for alcohol use disorder

Combined use of cannabis and alcohol may increase driving impairment and subjective intoxication

In-Depth [cross-sectional study]: This cross-sectional study aimed to assess whether alcohol use decreased between 2022 and 2024 and to evaluate differences across demographic subgroups. Serial cross-sectional data from the National Health Interview Survey (NHIS) from 2018 to 2024 were used to assess alcohol consumption among US adults. Outcomes included past-year prevalence of any and heavy alcohol use, with heavy use defined as ≥5 drinks on any day or ≥15 drinks per week for males and ≥4 drinks on any day or ≥8 drinks per week for females. The study included 114,352 respondents (24,965 in 2018; 30,829 in 2020; 26,806 in 2022; 31,752 in 2024). Compared with 2022, the 2024 national prevalence of any alcohol use decreased by 1.24% (95% confidence interval [CI], -2.46% to -0.02%), while heavy alcohol use decreased by 0.52% (95% CI, -1.00% to -0.05%). Reductions in any alcohol use were observed across most subgroups, particularly males (-1.76% [95% CI, -3.31% to -0.21%]), Generation Z (-3.96% [95% CI, -6.98% to -0.95%]), and White participants (-1.45% [95% CI, -2.83% to -0.06%]). Heavy alcohol use also declined across several subgroups, including adults aged 30 to 49 years (-1.67% [95% CI, -2.94% to -0.40%]), Millennials (-1.19% [95% CI, -2.08% to -0.30%]), White participants (-0.78% [95% CI, -1.37% to -0.17%]), non-Hispanic participants (-0.68% [95% CI, -1.21% to -0.15%]), and urban residents (-0.57% [95% CI, -1.08% to -0.06%]). Despite these declines, both outcomes remained at or above 2018 prepandemic levels. From 2018 to 2024, any alcohol use increased among adults aged 50 to 64 years (+2.53% [95% CI, +0.42% to +4.64%]) and Western residents (+3.30% [95% CI, +0.01% to +6.58%]). Heavy alcohol use also increased among adults aged 50 to 64 years (+2.08% [95% CI, +1.16% to +2.99%]) and Hispanic participants (+1.47% [95% CI, +0.54% to +2.39%]). Overall, alcohol use declined from 2022 to 2024 but remained at or above prepandemic levels.

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.



Tags: adultsAlcoholalcohol usestudyUse
Previous Post

High maternal egg-peanut intake not associated with reduced infant allergy

RelatedReports

Chronic Disease

Deficits in executive function are not universal among patients with alcohol use disorder

September 15, 2026
Chronic Disease

Few interventions improve posthospitalization follow-up for alcohol use disorder

September 14, 2026
Systematic review examines benefits and adverse effects of cannabinoid therapy
Emergency

Combined use of cannabis and alcohol may increase driving impairment and subjective intoxication

May 8, 2026
Increased risk of stillbirth recurrence after a previous stillbirth
Chronic Disease

Limited pharmacotherapy initiation during veteran hospitalizations for alcohol use disorder

May 4, 2026
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Alcohol use declines but remains above pre-pandemic levels
  • High maternal egg-peanut intake not associated with reduced infant allergy
  • The rotavirus vaccine (ROTASIIL) may reduce the incidence of hospitalization for rotavirus gastroenteritis in children
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.